Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Vemurafenib | IC50 | 23.0 [1], 31.4 [2] | |
| 4-(3-Pyridin-2-YL-1H-pyrazol-4-YL)quinoline | IC50 | 1400.0 [1] | |
| LY-2090314 | IC50 | 20000.0 [1] | |
| LY-3009120 | IC50 | 39.0 [1] | |
| 3-Imidazo[1,2-a]pyridin-3-yl-4-[10-(morpholine-4-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]pyrrole-2,5-dione | IC50 | 13400.0 [1] | |
MLA | "Quest Database™ Mixed lineage kinase 7 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 20 Jan. 2026, https://www.aatbio.com/data-sets/mixed-lineage-kinase-7-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, January 20). Quest Database™ Mixed lineage kinase 7 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/mixed-lineage-kinase-7-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |